Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-17

Clinical Trial Update: Efficacy and Safety of S (+) - Ibuprofen in Osteoarthritis Pain [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating efficacy and safety of S (+)-Ibuprofen in osteoarthritis pain has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • S(+)-Ibuprofen (S-ibuprofen (S(+)-enantiomer))

Snippet

Sponsor: Apsen Farmaceutica S.A. | Conditions: Osteoarthritis | Phase 2 | Status: COMPLETED